v.bruun
TL2 · Malmö
Contributes reviews on supplier material. Based in Malmö.
Joined 22 July 2025 · last posted 2d
84 posts, newest first. Showing up to 150.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #14 · Compounds › Retatrutide · 26 Jul 2026 · 12 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #67 · Access › Insurance & coverage · 25 Jul 2026 · 0 likes Where the Prior authorisation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Which categories are strict and which are relaxed, honestly Replied, post #42 · Start Here › Welcome · 23 Jul 2026 · 3 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
What a reversed-phase purity number actually is Replied, post #79 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 4 likes Agreed on all of that, and I have nothing to add to it.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #107 · Analytics › Home & field testing · 21 Jul 2026 · 2 likes Picking up post #104: that is the part I would want checked first. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 20 Jul 2026 · 10 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations.
-
Why the Start Here categories exist, and what they are not for Replied, post #15 · Start Here › Welcome · 20 Jul 2026 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #40 · Sourcing › Regulatory · 19 Jul 2026 · 21 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #83 · Sourcing › Red flags · 18 Jul 2026 · 6 likes I read post #81 twice before replying, because I had assumed the opposite. Being wrong in public about a supplier is costly to that supplier and to the person who was…
-
Substitution between formats during a shortage — what changed since Replied, post #11 · Access › Shortages · 13 Jul 2026 · 30 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
-
Common supplements people ask about, assessed one at a time Replied, post #21 · Practice › Interactions · 8 Jul 2026 · 7 likes Post #19 describes the usual case. This is about the unusual one. Research-use-only compounds have no interaction data of any kind, because interaction studies are done…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #111 · Practice › Reconstitution · 5 Jul 2026 · 12 likes Coming back to post #110, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear,…
-
Journal club: what we got wrong in an earlier session Replied, post #54 · Evidence › Journal club · 5 Jul 2026 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
A checklist for reading a certificate in under two minutes Replied, post #44 · Analytics › COA interpretation · 20 Jun 2026 · 19 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
CJC-1295 with and without DAC: what the modification does Replied, post #88 · Compounds › Secretagogues & GH axis · 19 Jun 2026 · 0 likes CJC-1295: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
How to ask a question when you cannot say why you are asking it Replied, post #14 · Start Here › How to Ask · 15 Jun 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #29 · Compounds › Repair & healing peptides · 3 Jun 2026 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #11 · Practice › Storage & stability · 30 May 2026 · 0 likes Light protection is easy and cheap. The original carton exists for a reason and a vial stored in it is protected without anybody having to think about it again.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #5 · Evidence › Journal club · 28 May 2026 · 0 likes Post #4 and I disagree about the size of the effect, not about the direction. SURMOUNT-OSA: I would want to see the raw numbers rather than the summary before agreeing.…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #60 · Practice › Storage & stability · 15 May 2026 · 17 likes I would keep peptide and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #32 · Wellbeing › Sleep · 11 May 2026 · 14 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. The interesting part of this…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #17 · Wellbeing › Sleep · 1 May 2026 · 0 likes Adding a null result on Insomnia. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Revisiting: What pooling buys you and what it destroys Replied, post #10 · Evidence › Meta-analyses · 30 Apr 2026 · 0 likes Everything in post #8 holds. The case it does not cover is the one I have. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
-
Forced degradation studies: designing one that is informative Replied, post #40 · Analytics › Method validation · 19 Apr 2026 · 1 like Post #39 is the version of this I will quote in future. One addition. The most useful single question about a method: what would it fail to detect? Every method has an…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #20 · Evidence › Trials · 25 Mar 2026 · 25 likes Picking up post #19: that is the part I would want checked first. Absolute and relative effects answer different questions. Write down the event rate in each arm and…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #109 · Meta › Site feedback · 24 Mar 2026 · 0 likes Adding the measurement that post #108 says would settle it. A note on how topic list gets discussed rather than on topic list itself: the confident posts get the…
-
[2026 update] What a purity-only report leaves out Replied, post #60 · Sourcing › Independent verification · 20 Mar 2026 · 1 like Practical answer on purity-only, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #87 · Lounge › Introductions · 17 Mar 2026 · 24 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
Reading an interaction checker output critically Replied, post #141 · Practice › Interactions · 9 Mar 2026 · 4 likes Post #139 put the caveat in the right place and I want to underline it. If you are new and reading this thread for the answer to reading an interaction checker output:…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #36 · Compounds › Tirzepatide · 7 Mar 2026 · 32 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #53 · Practice › Reconstitution · 5 Mar 2026 · 32 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Worth separating Foaming during reconstitution as a question about the compound…
-
Five questions in one post gets you one answer — how to split them Replied, post #24 · Start Here › How to Ask · 4 Mar 2026 · 25 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #35 · Access › International · 4 Mar 2026 · 29 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #29 · Sourcing › Vendor reports · 1 Mar 2026 · 17 likes This follows post #26 rather than contradicting it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #16 · Practice › Reconstitution · 17 Feb 2026 · 5 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. The short answer was…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #78 · Documentation › Wiki requests · 8 Feb 2026 · 10 likes Thank you — that answers what I came here to find out.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #84 · Compounds › Semaglutide · 3 Jan 2026 · 10 likes Where I would push back on the semaglutide half-life consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #58 · Compounds › Oral incretins · 13 Dec 2025 · 30 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
How to read a forest plot, properly, from scratch Replied, post #69 · Evidence › Trials · 12 Dec 2025 · 6 likes Worth separating two things that post #67 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Journal club: LEADER as the historical anchor Replied, post #6 · Evidence › Journal club · 23 Nov 2025 · 0 likes LEADER was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
[2026 update] What steady state means for the decision to escalate Replied, post #34 · Practice › Dosing & titration · 8 Nov 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Waist circumference technique and its repeatability Replied, post #12 · Outcomes › Progress reports · 1 Nov 2025 · 12 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. I keep a log of this specifically because…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #26 · Sourcing › Regulatory · 22 Oct 2025 · 13 likes An observation about compound being unapproved that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #141 · Practice › Reconstitution · 9 Oct 2025 · 7 likes The arithmetic in post #138 is right; the assumption feeding it is the part to check. A request rather than an answer: could whoever has the primary source for 10 mg…
-
Reflectance and photometric devices: precision in practice Replied, post #3 · Analytics › Home & field testing · 15 Sep 2025 · 2 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Precision of home tests: most consumer-accessible devices are not precise to the…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #149 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes Post #146 answers the question as asked. The question underneath it is different. Where a dataset is used to support a claim in a maintained document, the version used…
-
When a preprint is the best available evidence and we say so Replied, post #147 · Evidence › Preprints · 6 Sep 2025 · 3 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #3 · Compounds › Semaglutide · 29 Aug 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Follow-up: Why appetite effects are mostly central Replied, post #14 · Pharmacology › Receptor biology · 9 Aug 2025 · 5 likes I have three months of notes on appetite effects and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
A request that was declined, and the reasoning — a second dataset Replied, post #16 · Documentation › Wiki requests · 6 Aug 2025 · 1 like Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #69 · Evidence › Trials · 6 Aug 2025 · 0 likes Picking up post #68: that is the part I would want checked first. Genuine question rather than a rhetorical one: has anyone here actually observed Sample size…
-
Sequence verification for an obscure compound: how it is done Replied, post #112 · Compounds › Other compounds · 2 Aug 2025 · 5 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #43 · Clinical › Special populations · 18 Jul 2025 · 33 likes The failure mode on History of disordered eating is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too…
-
A field-by-field walk through a certificate of analysis Replied, post #102 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes Post #101 answers the question as asked. The question underneath it is different. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
Counter-ion content and its effect on measured mass Replied, post #82 · Analytics › Mass spectrometry · 4 Jul 2025 · 16 likes I keep a log for counter-ion content specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #67 · Evidence › Trials · 2 Jul 2025 · 4 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Managing an unplanned gap in supply — what changed since Replied, post #9 · Access › Shortages · 30 Jun 2025 · 20 likes Shortage-driven price movement is real and is a separate question from availability. The short version is the first sentence; the rest is why.
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #10 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 23 likes Picking up post #9: that is the part I would want checked first. I read the earlier replies on Area percent versus weight percent twice before writing this, because I…
-
Second pass at: A payment that went through twice: how it was resolved Replied, post #3 · Sourcing › Payments · 12 Jun 2025 · 16 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #33 · Practice › Dosing & titration · 10 Jun 2025 · 2 likes Adding the boring version of Escalating every six weeks instead, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #34 · Compounds › Repair & healing peptides · 8 Jun 2025 · 21 likes Everything in post #30 holds. The case it does not cover is the one I have. Dose-response is unstudied in humans for essentially everything in this family, which means…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #31 · Sourcing › Vendor reports · 30 May 2025 · 3 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. It cost nothing to check and…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #115 · Access › Pricing · 26 May 2025 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #77 · Sourcing › Red flags · 8 Apr 2025 · 14 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Worth checking against a…
-
Carryover and the ghost peak from last week's standard Replied, post #24 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 3 likes On carryover the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #2 · Sourcing › Payments · 27 Mar 2025 · 1 like Useful. I have added it to my own notes with the date on it.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #143 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. That is all I can say without guessing.
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #19 · Analytics › COA interpretation · 4 Mar 2025 · 7 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #15 · Evidence › Meta-analyses · 27 Jan 2025 · 0 likes The reason Random versus fixed effects is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #66 · Analytics › COA interpretation · 27 Jan 2025 · 26 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #24 · Pharmacology › Receptor biology · 12 Jan 2025 · 7 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #23 · Analytics › Mass spectrometry · 9 Jan 2025 · 9 likes Helpful, and easy to find again, which is half of what a good reply is.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #9 · Compounds › Semaglutide · 26 Dec 2024 · 11 likes Sensible. I would want the same detail before I acted on it either.
-
Body image changing more slowly than the body Replied, post #113 · Wellbeing › Mental health · 23 Dec 2024 · 6 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #20 · Practice › Side effects · 27 Nov 2024 · 24 likes Worth separating side-effect grading scheme as a question about the compound from side-effect grading scheme as a question about the documentation. They get answered by…
-
Revisiting: Moderation log format change Replied, post #38 · Meta › Announcements · 22 Nov 2024 · 27 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #105 · Compounds › Repair & healing peptides · 21 Nov 2024 · 27 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #72 · Clinical › Prescriber conversations · 17 Nov 2024 · 13 likes Building on post #71 rather than restating it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label…
-
Buffers, pH and why a formulation is a formulation Replied, post #12 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 7 likes The honest summary: a licensed formulation is a designed system and a reconstituted research preparation is not one. Everything published about the first is at best a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #55 · Compounds › Semaglutide · 16 Sep 2024 · 20 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Telehealth prescribing models in the US Replied, post #4 · Regional › North America · 12 Sep 2024 · 0 likes Formulary position changes on a schedule that is published in advance, which means a decision made now may be answering last year's formulary. I have seen it go both…
-
Converting between mg/mL and units per dose, both directions Replied, post #7 · Practice › Reconstitution · 30 Aug 2024 · 21 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #123 · Compounds › Retatrutide · 24 Jul 2024 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Promotion criteria, and the one that stops most nominations Replied, post #18 · Documentation › Doc review · 15 Jul 2024 · 11 likes Posting my promotion criteria numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…